Cadenza Bio, Inc. filed a Form D with the Securities and Exchange Commission on 2025-08-28.
Cadenza Bio, Inc. filed a Form D notice of an exempt securities offering with the SEC on August 28, 2025. The filing reports $2.44M sold. Its industry group is Biotechnology. It names Carol Curtis (Executive Officer, Director), Elaine Hamm (Executive Officer, Director), Tom Denison (Director) (SEC Form D, August 28, 2025).
Is this your company?
Sell to companies like Cadenza Bio, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-08-28 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Cadenza Bio, Inc.
Free to see. No signup.
More on the people and the money behind Cadenza Bio, Inc., from the filings we hold.
Biotechnology raises filed within 90 days of this one, largest first.
Get an email when Cadenza Bio, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Cadenza Bio, Inc. raises, hires or launches. No email unless you switch it on.
Watch Cadenza Bio, Inc. →Get the full cited report on Cadenza Bio, Inc.
What the filing shows about Cadenza Bio, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Cadenza Bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Cadenza Bio, Inc.'s address as 14504 Chambord Drive, Yukon, OK 73099.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Cadenza Bio, Inc. is a registered filer with the SEC (CIK 2083534) and has filed since 2025-08-28. 1 filing is on record, the latest on 2025-08-28.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Cadenza Bio, Inc.'s Form D of 2025-08-28 names Carol Curtis, Elaine Hamm and Tom Denison as its officers, directors or promoters.
Its new offerings report $2.44M sold across 1 offering, as its own filings state.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
Carol Curtis is named as Executive Officer and Director on the Form D that Cadenza Bio, Inc. filed with the SEC on 28 August 2025, one of 3 people that filing names.
Elaine Hamm is named as Executive Officer and Director on the Form D that Cadenza Bio, Inc. filed with the SEC on 28 August 2025, one of 3 people that filing names.
Tom Denison is named as Director on the Form D that Cadenza Bio, Inc. filed with the SEC on 28 August 2025, one of 3 people that filing names.
3 people named on the filing — 2 holding an executive role and 1 as a director only.
Named as of the 2025-08-28 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Cadenza Bio, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Cadenza Bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Cadenza Bio, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Cadenza Bio, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Cadenza Bio, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Cadenza Bio, Inc.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/cadenza-bio-inc-form-d-25000001